Navigation Links
Novel mechanism found that may boost impaired function of leukemia protein
Date:2/29/2008

NEW YORK, February 29, 2008 A new study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia. The protein, called AML1, plays a critical role in the development of the blood system and in the production of platelets and immune cells. The findings are published in the March 1, 2008, issue of Genes & Development.

According to the study, investigators identified the methyltransferase enzyme that controls the activity of the normal AML1 protein also called RUNX1 demonstrating its ability to regulate the function of transcription factors, proteins that control cell fate by turning genes on or off. The researchers found that the cellular pathways that regulate the activity of the normal AML1 protein through a process called arginine methylation cannot similarly regulate the activity of AML1-ETO, a protein associated with causing acute leukemia.

Methylation is the process by which methyltransferases catalyze the attachment of a methyl group to DNA or protein in order to regulate gene expression or protein function. Demethylase enzymes that remove methyl groups from proteins have only recently been discovered.

By manipulating the activity of these enzymes, it may be possible to promote the activity of the normal protein, and thereby lessen the impact of the protein that promotes leukemia, said the studys senior author Stephen D. Nimer, MD, Chief of the Hematology Service at MSKCC. We are just beginning to explore whether we can tilt the balance toward a normally functioning AML1 protein in leukemic cells and either trigger their death or their reversion to normal behavior.

There are currently no available drugs that target protein methylation, although two drugs that target DNA methylation are FDA approved for treating patients with myelodysplastic syndromes.

We hope to utilize these new fi
'/>"/>

Contact: Esther Napolitano
napolite@mskcc.org
212-639-3139
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Novel method to reveal drug targets
2. Novel link between excessive nutrient levels and insulin resistance
3. Novel organic metal hybrids that will revolutionize materials science and chemical engineering
4. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
5. Novel approach strips staph of virulence
6. UCSD research team identifies novel anticancer drug from the sea
7. Novel compound may lessen heart attack damage
8. Novel molecules developed at UB can boost vaccine potency
9. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
10. Novel vaccine concept developed by scientists at the Wistar Institute
11. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... According to a May 6, 2013 CBS News article, ... tanning salons in the US may soon have to ... to see cancer warnings on indoor tanning beds ... for the use of indoor tanning and sun beds. The ... increasingly common over the last few decades (Go to goo.gl/TCT6m). ...
(Date:5/20/2013)... UT (PRWEB) May 20, 2013 Salt Lake ... of Select Health’s Select 25 winners for 2013. ... from Select Health. Know Greater Heroes is a leadership training ... schools to teach children how to eat right, be active, ... participate in the Know Greater Heroes program each year, and ...
(Date:5/20/2013)... May 20, 2013 The Muscular ... community leaders behind bars for good at an Executive ... beginning at 9 a.m. , More than 100 ... Lock-Up to benefit individuals and families affected by muscle ... city officials, local celebrities, realtors, doctors, attorneys, bankers, and ...
(Date:5/20/2013)... 2013 Dorland Health, a division ... fourth annual Case In Point Platinum Awards, recognizing ... ensuring the system is patient- and family-centric, safe ... and creative work across the healthcare system that ... transitions of care through effective care coordination across ...
(Date:5/20/2013)... Diego, CA (PRWEB) May 20, 2013 ... and around the world will make the pilgrimage to ... the 2nd annual Digital Health Summer Summit ... conference provides a unique forum to showcase the latest ... and best practices, and network with some of industry’s ...
Breaking Medicine News(10 mins):Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4
... recommended by Bradley Kropp of Faculty of 1000 Medicine, ... the recovery of bowel function after gastrointestinal surgery ... decades. , Authors of the paper published in ... half of them 5 pieces of chewing gum per ...
... Conscious Americans Driving Dental Implant and Facial ... Millennium Research Group, WALTHAM, Mass., Feb. 27 ... Volumes 2008 report, dental implants,and facial aesthetic procedures ... rates (CAGR). This stands in stark contrast to ...
... Feb. 27 Avista Capital Partners, a leading,private ... Gerhard Kurz, a,40-year veteran of the offshore energy ... Mr. Kurz was most recently President and ... of marine support and,transportation services, in which the ...
... daily,Black History Month 2008 "Profile America" feature from the ... INSURANCE, Profile America for the 27th day of ... U.S. population can be measured in many ways. One ... annual median income,for African-American households is just under $32,000. ...
... The Walter and Eliza Hall,Institute of Medical Research ... company, Genentech, a leading biotechnology company,based in South ... tripartite research,collaboration to discover new anti-cancer drugs., ... leaders,in this field may increase the chance of ...
... ... Food, Feed, ... leadership changes to strengthen its leading biotechnology,position and better serve the ... feed and fuel markets., "Across its business segments, DuPont is ...
Cached Medicine News:Health News:Cosmetic Procedures Outpace All Other Surgical Procedures 2Health News:Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz 2Health News:Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz 3Health News:Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 3Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 4
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- It is no secret ... third being overweight or obese gyms and supplement companies are ... the condition is primarily related to dietary issues and a ... the result of a glandular problem or even a vitamin ... common vitamin deficiency is a lack of vitamin b12 ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11
... N.J., May 03, 2007 /PRNewswire-FirstCall/ --,Alpharma ... pharmaceutical company,through its Pharmaceuticals Division, this ... study of its investigational,abuse-deterrent, extended-release opioid ... the American Pain Society in Washington, ...
... /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced today that ... International Conference on Antiviral,Research being held in ... virus (HCV) polymerase inhibitor,discovered by Genelabs. , ... D. Roberts,Ph.D., Director of Medicinal Chemistry at ...
Cached Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: